Congressman Chabot Tours UC Neuroscience Lab

U.S. Rep. Steve Chabot, who represents Ohio’s 1st District in the U.S. House of Representatives, visited the UC College of Medicine Monday, Sept. 21, for a laboratory tour and research discussion.

Chabot began his visit in the CARE/Crawley Building with a tour of the Selma Schottenstein Harris Laboratory for Research in Parkinson's, which is directed by Kim Seroogy, PhD. Seroogy, a professor in the Department of Neurology and Rehabilitation Medicine and vice chair of basic research in the department, is a member of the research team at the UC Neuroscience Institute’s James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders.

During the tour, Seroogy gave an overview of his research, which examines the beneficial effects neuroprotective growth factors and the detrimental effects of stress and depression on the progression of Parkinson’s. Seroogy was accompanied by Ryan Makinson, a doctoral student in neuroscience who helped coordinate Chabot’s visit.

Following the lab tour, Chabot, Seroogy and Makinson participated in a discussion of neuroscience research and training the next generation of neuroscientists at UC with Mark Baccei, PhD, Department of Anesthesiology and associate director of the Neuroscience Graduate Program; Marshall "Chip” Montrose, PhD, vice provost and dean of the graduate school; and Mike Carroll, assistant vice president for government relations.

Chabot’s visit followed a visit earlier this month by U.S. Rep. Brad Wenstrup, who represents Ohio’s 2nd District in the House of Representatives. Chabot was also on the medical campus May 4 as a speaker for the opening ceremony of Research Week 2015.

Related Stories

2

At least two weather patterns increase headaches, UC study suggests

June 4, 2026

University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.